Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes MellitusBusiness Wire • 06/26/23
FDA Approves Pfizer's LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia AreataBusiness Wire • 06/23/23
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis saysCNBC • 06/22/23
Pfizer Invites Public to View and Listen to Webcast of August 1 Conference Call with AnalystsBusiness Wire • 06/20/23
Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head startCNBC • 06/20/23